Articolo in rivista, 2022, ENG, 10.3390/pharmaceutics14102079

Mesoporous Silica Particles Functionalized with Newly Extracted Fish Oil (Omeg@Silica) Reducing IL-8 Counteract Cell Migration in NSCLC Cell Lines

D'Anna, Claudia; Di Sano, Caterina; Di Vincenzo, Serena; Taverna, Simona; Cammarata, Giuseppe; Scurria, Antonino; Pagliaro, Mario; Ciriminna, Rosaria; Pace, Elisabetta

CNR - Istituto di Farmacologia Traslazionale; Istituto Per Lo Studio Dei Materiali Nanostrutturati, Rome

Lung cancer is one of the leading forms of cancer in developed countries. Interleukin-8 (IL-8), a pro-inflammatory cytokine, exerts relevant effects in cancer growth and progression, including angiogenesis and metastasis in lung cancer. Mesoporous silica particles, functionalized with newly extracted fish oil (Omeg@Silica), are more effective than the fish oil alone in anti-proliferative and pro-apoptotic effects in non-small cell lung cancer (NSCLC) cell lines. The mechanisms that explain this efficacy are not yet understood. The aim of the present study is therefore to decipher the anti-cancer effects of a formulation of Omeg@Silica in aqueous ethanol (FOS) in adenocarcinoma (A549) and muco-epidermoid (NCI-H292) lung cancer cells, evaluating cell migration, as well as IL-8, NF-?B, and miRNA-21 expression. Results show that in both cell lines, FOS was more efficient than oil alone, in decreasing cell migration and IL-8 gene expression. FOS reduced IL-8 protein release in both cell lines, but this effect was only stronger than the oil alone in A549. In A549, FOS was able to reduce miRNA-21 and transcription factor NF-?B nuclear expression. Taken together, these data support the potential use of the Omeg@Silica as an add-on therapy for NSCLC. Dedicated studies which prove clinical efficacy are needed.

Pharmaceutics 14 (10)

Keywords

cancer cell migration, fish oil, inflammation, lung cancer cells, omega-3, PUFA

CNR authors

Scurria Antonino, Ciriminna Rosaria, Pace Elisabetta, Pagliaro Mario, D Anna Claudia, Di Sano Caterina, Cammarata Giuseppe, Di Vincenzo Serena, Taverna Simona

CNR institutes

ISMN – Istituto per lo studio dei materiali nanostrutturati, IFT – Istituto di Farmacologia Traslazionale

ID: 482685

Year: 2022

Type: Articolo in rivista

Creation: 2023-06-15 16:33:43.000

Last update: 2023-08-30 11:37:29.000

External IDs

CNR OAI-PMH: oai:it.cnr:prodotti:482685

DOI: 10.3390/pharmaceutics14102079

Scopus: 2-s2.0-85140844580

ISI Web of Science (WOS): 000873710400001